1/24
Comprehensive practice flashcards covering receptor families, signaling mechanisms, and their pharmacological implications based on the BIS215 lecture notes.
How does Dr Elizabeth Seward define the goal of knowing signaling mechanisms in pharmacology?
To design assays used at the cellular level in drug discovery and to predict the consequences of mutations which give rise to disease.
What are the four general functions of a receptor as listed in the lecture notes?
Recognize stimulus, transfer stimulus into cell, amplification of cytoplasmic signal, modulation of effector systems over time, and adaptation of the system through feedback.
How are receptor families primarily defined?
They are defined by their structure and signaling mechanisms.
What structural change is required for the opening of a ligand-gated ion channel like the nicotinic receptor?
A ligand must bind to the channel to cause a conformational change that leads to the opening of the pore.
How many subunits typically make up a nicotinic acetylcholine receptor, and how many ligands are required for activation?
It consists of 5 subunits, and 2 ligands are required for the necessary conformational change to twist the aqueous pore open.
At which receptor does nicotine act to cause its addictive effect in the CNS reward pathway?
The Nicotinic Acetylcholine Receptor, where it releases dopamine.
What is meant by the term 'Orphan' receptors in the context of GPCRs?
Receptors that have been identified structurally but whose actual ligand is currently unknown.
What is the characteristic structural feature of Type 2 G protein-Coupled Receptors (GPCRs)?
They possess 7 transmembrane domains.
Which specific GPCR is found most commonly on nerve cells in the brain, spinal cord, and other organs?
The cannabinoid 1 (CB1) receptor.
Where are cannabinoid 2 (CB2) receptors primarily located according to the notes?
In the reproductive organs, immune system, and peripheral nervous system.
What are the components of 'Canonical' signaling by GPCRs?
Adenylyl Cyclase, cAMP, IP3, DAG, PKA, PKC, Gq, Gs, Gi, PI(4,5)P2, PLCb, and Arrestin.
What distinguishes Type 3 Receptor Tyrosine Kinases (RTKs) from other receptor types regarding their structure?
They have a single transmembrane domain and usually require two receptors to come together (dimerization) to activate signaling.
What is the physiological consequence of activating growth factor receptors (RTKs) that are mutated?
Uncontrolled growth, which is involved in many cancers.
In RTK signaling, what is the correct sequence for the kinase cascade leading to the nucleus?
Activation of Ras (via GDP/GTP exchange), phosphorylation of Raf, phosphorylation of Mek, and phosphorylation of MAP kinase.
Why are Cytokine Receptors described as 'Tyrosine Kinase linked' rather than being kinases themselves?
Because the kinase is not built into the receptor but is brought by an associated protein, such as Janus Kinase (JAK).
What percentage of drugs target Type 4 Nuclear Receptors?
10 of drugs target nuclear receptors.
What is the function of the Pregnane X Receptor (PXR)?
To detect xenobiotics (foreign molecules) and induce drug metabolizing enzymes.
What is the clinical significance of CYP3A in pharmacology?
It metabolizes approximately 60 of prescription drugs, affecting pharmacokinetics.
The muscle-type nicotinic receptor is mainly permeable to which ions?
Mainly Na+ and K+ ions.
How does the ion permeability of CNS-type nicotinic receptors like (α7)5 differ from muscle types?
They are highly selective towards Ca2+, which acts like a second messenger to activate different proteins.
Which autoimmune disease is caused by autoantibodies against receptors?
Myasthenia gravis.
What condition is associated with mutations in ligand-gated ion channels?
Epilepsy.
What are the common clinical manifestations of thyroid hypersecretion (Graves disease)?
High metabolic rate, increased skin temperature, nervousness, tremor, tachycardia, and bulging eyes.
What are the four common protein drug targets listed in the lecture summary?
Receptors, ion channels, enzymes, and transporters.
How is the pharmacological opportunity provided by multiple subunits in ligand-gated ion channels described?
Complexity provides diversity, allowing for the development of drugs selective to particular receptor subtypes based on subunit combinations.